Easywell Biomedical Inc (1799)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Easywell Biomedical Inc (1799) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012876
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Easywell Biomedical Inc (Easywell), formerly Actherm Inc is a health care company that offers medical devices and testing devices. The company offers pharmaceuticals, regenerative medicines and medical devices, among others. Its medical devices comprise pain management systems, non-contact, forehead infrared thermometer, infrared ear thermometer and digital clinical thermometers, among others. Actherm offers cryopreservation media, cell delivery systems and scale-up technologies for development of its regenerative medicines. The company provides products in simple pack, cradle pack, desktop pack and wall mount packs, among others. It sells its products through a network of distributors in Hsinchu. Actherm is headquartered in HsinChu, Taiwan.

Easywell Biomedical Inc (1799) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Easywell Biomedical Inc , Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Easywell Biomedical Inc , Medical Equipment Deals By Type, 2011 to YTD 2017 6
Easywell Biomedical Inc , Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Easywell Biomedical Inc , Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Easywell Biomedical Inc , Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Easywell Biomedical Inc , Medical Equipment, Deal Details 10
Equity Offering 10
Easywell Biomedical to Raise USD13 Million in Public Offering of Shares 10
Actherm Announces Private Placement Of Common Stock For US$6.7 Million 11
Actherm Prices Private Placement Of Shares For US$6.6 Million 12
Debt Offering 13
Easywell Biomedical Raises USD6.2 Million in Public Offering of Bonds Due 2019 13
Acquisition 14
Easywell Biomedical to Acquire 85.58% Stake in Transwell Biotech 14
Easywell Biomedical to Acquire 14.42% Stake in Transwell Biotech 15
Easywell Biomedical Inc – Key Competitors 16
Easywell Biomedical Inc – Key Employees 17
Easywell Biomedical Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Easywell Biomedical Inc , Medical Equipment, Key Facts, 2016 2
Easywell Biomedical Inc , Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Easywell Biomedical Inc , Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Easywell Biomedical Inc , Medical Equipment Deals By Type, 2011 to YTD 2017 6
Easywell Biomedical Inc , Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Easywell Biomedical Inc , Deals By Market, 2011 to YTD 2017 8
Easywell Biomedical Inc , Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Easywell Biomedical to Raise USD13 Million in Public Offering of Shares 10
Actherm Announces Private Placement Of Common Stock For US$6.7 Million 11
Actherm Prices Private Placement Of Shares For US$6.6 Million 12
Easywell Biomedical Raises USD6.2 Million in Public Offering of Bonds Due 2019 13
Easywell Biomedical to Acquire 85.58% Stake in Transwell Biotech 14
Easywell Biomedical to Acquire 14.42% Stake in Transwell Biotech 15
Easywell Biomedical Inc , Key Competitors 16
Easywell Biomedical Inc , Key Employees 17
Easywell Biomedical Inc , Other Locations 18
Easywell Biomedical Inc , Subsidiaries 18

★海外企業調査レポート[Easywell Biomedical Inc (1799)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Klox Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Klox Technologies Inc (Klox Technologies) is a biomedical technology company that researches, develops and commercializes fluorescence biomodulation (FB) technology products for the treatment of skin and soft tissue disorders. The company develops FB systems to address conditions in the ther …
  • Croma-Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Principia Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Principia Biopharma Inc (Principia Biopharma) is a biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase (BTK) inhibitor, Interleukin …
  • Ascena Retail Group, Inc.:企業の戦略・SWOT・財務分析
    Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dartmouth College-製薬・医療分野:企業M&A・提携分析
    Summary Dartmouth College (Dartmouth) is an academic and research institute that offers undergraduate and graduate educational programs. The institute offers programs in the fields of arts, sciences, business administration, medicine, and engineering. It operates through various faculties such as th …
  • Federal Signal Corp (FSS):企業の財務・戦略的SWOT分析
    Federal Signal Corp (FSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SkylineDx BV:企業の製品パイプライン分析
    Summary SkylineDx BV (SkylineDx) is a developer and commercializer of gene signature-based diagnostic tests for personalized medicine in oncology. The company offers MMprofiler and AMLprofiler molecular diagnostic tests for blood cancers. Its AMLprofiler is a vitro diagnostic test that recognizes ac …
  • PathoQuest SAS-医療機器分野:企業M&A・提携分析
    Summary PathoQuest SAS (PathoQuest) is a biotechnology company that offers game changing metagenomics approach to improve the breadth of pathogen detection. The company offers automated bioinformatics software that provide comprehensive pathogens database to produce microbiome reports. Its testing a …
  • HUK-COBURG-Versicherungsgruppe:企業の戦略・SWOT・財務情報
    HUK-COBURG-Versicherungsgruppe - Strategy, SWOT and Corporate Finance Report Summary HUK-COBURG-Versicherungsgruppe - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • MADO Ice Cream & Foodstuffs Co., Ltd.:企業の戦略・SWOT・財務分析
    MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Keppel Corporation Limited:企業の戦略・SWOT・財務分析
    Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Barton Malow Company:企業の戦略・SWOT・財務情報
    Barton Malow Company - Strategy, SWOT and Corporate Finance Report Summary Barton Malow Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Celyad SA (CYAD):企業の財務・戦略的SWOT分析
    Summary Celyad SA (Celyad), formerly Cardio3 BioSciences, is a clinical-stage biopharmaceutical company that offers discovery and development of engineered cell therapies. The company offers C-Cure, a cell-based reparative therapy to treat heart failure. It offers C-Cathez, an intraventricular injec …
  • Cielo Wind Power, LP:電力:M&Aディール及び事業提携情報
    Summary Cielo Wind Power, LP (Cielo Wind) is a wind power project development company. It designs, develops, owns and operates utility-grade wind power projects. The company provides a wide range of services including engineering, construction, operations and maintenance, land procurement, meteorolo …
  • Caledonia Investments plc:企業の戦略・SWOT・財務情報
    Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report Summary Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mitsubishi Estate Co., Ltd.:企業の戦略・SWOT・財務情報
    Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Tiger Brands Ltd (TBS):企業の財務・戦略的SWOT分析
    Tiger Brands Ltd (TBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CIBC Wealth Management:企業の戦略・SWOT・財務情報
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆